Serum-mediated immunosuppression: A possible tumor marker in patients with ovarian carcinoma
- 1 May 1985
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 21 (1) , 94-100
- https://doi.org/10.1016/0090-8258(85)90237-9
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Whole pelvic irradiation in stage I endometrial carcinoma: Changes in numbers and reactivities of some blood lymphocyte subpopulationsGynecologic Oncology, 1982
- Nonspecific immunosuppressive factors in malignant ascites: further characterization and possible relationship to erythrocyte receptors of human peripheral T cells.The Journal of Immunology, 1981
- Acute-phase reactant proteins and complement components and inhibitors in patients with ovarian cancerGynecologic Oncology, 1981
- INHIBITION OF INVITRO LYMPHOCYTE FUNCTION BY CYSTIC AND ASCITIC FLUIDS FROM OVARIAN-CANCER PATIENTS1979
- IMMUNOSUPPRESSIVE ACTIVITY OF ASCITIC FLUID FROM PATIENTS WITH CANCER METASTATIC TO PERITONEUM1977
- Association of Anergy with an Immunosuppressive Peptide Fraction in the Serum of Patients with CancerNew England Journal of Medicine, 1974
- A Certain Symmetry : Histocompatibility Antigens compared with Immunocyte ReceptorsNature, 1970